Get the Stockscreener App
24.35
1.00%
0.24
Kardigan Inc stock is traded at $24.35, with a volume of 342.61K.
It is up +1.00% in the last 24 hours and up +0.00% over the past month.
Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.
See More
Previous Close:
$24.11
Open:
$23.98
24h Volume:
342.61K
Relative Volume:
3.47
Market Cap:
$2.18B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+7.84%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$22.88
$25.58
1-Week Range:
$21.88
$27.00
52-Week Range:
$20.07
$27.00
Kardigan Inc Stock (KARD) Company Profile
Compare KARD vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KARD
Kardigan Inc
|
24.35 | 2.13B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
528.04 | 126.07B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
654.27 | 65.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
939.68 | 57.70B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
312.78 | 40.19B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
189.24 | 39.82B | 742.00K | -1.37B | -1.07B | -7.0731 |
Kardigan Inc Stock (KARD) Latest News
HRTG entities report 16.9M shares in Kardigan (KARD) — 18.2% stake - Stock Titan
Kardigan (KARD) backer ARCH discloses 16.2% ownership stake post-IPO - Stock Titan
ARCH Venture Fund XIII Discloses Investment in Kardigan with 16.2% Stake - TradingView
Kardigan (KARD) Stock Trends and Sentiment 2026 $KARD - MarketBeat
We've developed a first-of-its-kind medicine to battle cardiovascular disease: Kardigan CEO - Fox Business
KARD Price History for Kardigan Stock - Barchart.com
Perceptive Advisors’ Kardigan (KARD) stake tops 8% with IPO lock-up - Stock Titan
Kardigan(KARD) Stock Options Chain | Quotes & News - Moomoo
Kardigan rises in Nasdaq debut after upsized $400 million IPO - AOL.com
KARD | Kardigan, Inc. Common Stock Institutional Ownership - Quiver Quantitative
Kardigan (NASDAQ: KARD) fund boosts stake with 3.13M-share open-market buy - Stock Titan
Kardigan (NASDAQ: KARD) major holders detail warrant and preferred stock positions - Stock Titan
ARCH Venture Fund boosts Kardigan (KARD) stake with 1.25M-share open-market buy - Stock Titan
ARCH Venture Fund XIII boosts Kardigan (KARD) stake with 1.25M-share purchase - Stock Titan
KARD|Kardigan Ord Shs|Price:22.150|Chg%:-0.62 - TradingKey
Kardigan closes $460 million IPO, exercises option - scanx.trade
Biotech stock sends Wall Street surprising signal - thestreet.com
Kardigan (KARD) sets IPO of 23.3M shares at $14–$16 range - Stock Titan
How Kardigan spun deal leftovers into a $400M IPO - BioPharma Dive
Form 8K Kardigan For: 23 June By Investing.com - Investing.com Nigeria
Kardigan, Inc. Amends Charter and Bylaws Ahead of IPO: Key Changes to Stock Structure, Governance, and Shareholder Rights – Minichart - Minichart
Governance shift at Kardigan (NASDAQ: KARD) as new charter and bylaws take effect - Stock Titan
Kardigan Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - BioSpace
Kardigan closes $460 million IPO on Nasdaq By Investing.com - Investing.com India
[Form 4] Kardigan, Inc. Insider Trading Activity - Stock Titan
ARCH XIII converts Kardigan (NASDAQ: KARD) preferred stock into 13.8M common shares - Stock Titan
Kardigan (KARD) Chief Strategy Officer receives 79,640 restricted stock units - Stock Titan
Kardigan (KARD) director awarded 20,706 RSUs vesting in 2028 - Stock Titan
Kardigan (KARD) director linked fund converts preferred to 13.8M shares, gets RSU grant - Stock Titan
Kardigan (KARD) Chief Legal Officer awarded 47,784 RSUs vesting in 2028 - Stock Titan
Kardigan (KARD) CFO receives 79,640 restricted stock units vesting in 2028 - Stock Titan
Kardigan (KARD) director awarded 20,706 restricted stock units - Stock Titan
Kardigan (KARD) director Walbert receives RSU and stock option grants - Stock Titan
Kardigan (KARD) grants director Douglas Giordano 20,706 RSUs - Stock Titan
Kardigan (KARD) CMO Edelberg granted RSUs and converts Series B preferred - Stock Titan
Kardigan closes $460 million IPO on Nasdaq - Investing.com UK
Kardigan Closes $460 Million IPO - Moomoo
Kardigan raises $460M in IPO on Nasdaq By Investing.com - Investing.com South Africa
Kardigan raises $460M in IPO on Nasdaq - Investing.com UK
Kardigan Inc Stock (KARD) Financials Data
There is no financial data for Kardigan Inc (KARD). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Kardigan Inc Stock (KARD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BERNS PAUL L | Director |
Jun 22 '26 |
Buy |
16.00 |
1,250,000 |
20,000,000 |
15,042,035 |
| ARCH Venture Partners XIII, LL | Director |
Jun 22 '26 |
Buy |
16.00 |
1,250,000 |
20,000,000 |
15,042,035 |
3.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):